Juan Ignacio Arenas Mirave-rekin lankidetzan egindako argitalpenak (8)

2020

  1. Efficacy and safety of the combination of pravastatin and sorafenib for the treatment of advanced hepatocellular carcinoma (Estahep clinical trial)

    Cancers, Vol. 12, Núm. 7, pp. 1-14

2015

  1. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

2012

  1. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease

    European Journal of Radiology, Vol. 81, Núm. 6, pp. 1122-1127

  2. Effect of neoadjuvant chemotherapy in hepatic steatosis

    Chemotherapy, Vol. 58, Núm. 2, pp. 89-94

  3. Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models

    Cancer Cell International, Vol. 12

2008

  1. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis

    World Journal of Gastroenterology, Vol. 14, Núm. 10, pp. 1521-1527

1996

  1. Abscesos hepáticos múltiples, peritonitis y enteritis aguda por Klebsiella pneumoniae.

    Gastroenterología y hepatología

  2. Gastric adenocarcinoma in hamartomatous polyp in Peutz-Jeghers syndrome

    Gastroenterología y hepatología, Vol. 19, Núm. 9, pp. 452-455